717 related articles for article (PubMed ID: 17328080)
1. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
[TBL] [Abstract][Full Text] [Related]
3. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
4. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
6. Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression.
van der Kuyl AC; van den Burg R; Zorgdrager F; Groot F; Berkhout B; Cornelissen M
PLoS One; 2007 Feb; 2(2):e257. PubMed ID: 17330143
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery.
Ono S; Tsujimoto H; Hiraki S; Takahata R; Kinoshita M; Mochizuki H
Am J Surg; 2005 Sep; 190(3):439-44. PubMed ID: 16105533
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
[TBL] [Abstract][Full Text] [Related]
9. Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease.
Xiong YS; Zhou YH; Rong GH; Wu WL; Liang Y; Yang ZX; Geng HL; Zhong RQ
Clin Biochem; 2009 Jul; 42(10-11):1057-63. PubMed ID: 19285973
[TBL] [Abstract][Full Text] [Related]
10. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
Xiong YS; Cheng Y; Lin QS; Wu AL; Yu J; Li C; Sun Y; Zhong RQ; Wu LJ
Rheumatology (Oxford); 2014 Feb; 53(2):250-9. PubMed ID: 24196391
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses.
Cook EB; Stahl JL; Esnault S; Barney NP; Graziano FM
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):486-97. PubMed ID: 15875531
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
[TBL] [Abstract][Full Text] [Related]
19. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
[TBL] [Abstract][Full Text] [Related]
20. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon.
Eantuzzi L; Eid P; Malorni W; Rainaldi G; Gauzzi MC; Pellegrini S; Belardelli F; Gessani S
Eur J Immunol; 1997 May; 27(5):1075-81. PubMed ID: 9174595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
